Raines J, Buth J, Brewster D C, Darling R C
J Trauma. 1976 Aug;16(08):616-23.
Blood obtained by intraoperative autotransfusion is: 1) readily available 2) sterile 3) compatible 4) normothermic 5) inexpensive and may be infused rapidly for volume support. We have made extensive modifications to commercially available equipment in order to provide a safe, effective IAT. The effects of IAT in our series of 85 patients are outlined below. Red Cell Mass is reduced after IAT because of irretrievable blood loss and hemolysis, and may be controlled by homologous transfusion when necessary. Red Cell Survival is normal after IAT. Hemolysis. Plasma free hemoglobin is consistently elevated after IAT, but clears within 24 hours. Platelets are normal for patients autotransfused less than 3,500 ml; micropore filters should not be used in cases where greater than 3,500 ml blood is expected to be reinfused; in cases where greater than 3,500 ml is reinfused, 10 units of platelets are recommended for every 3,000 ml of blood reinfused; IAT does effect platelets function; however, platelets circulating within the patient function normally. Coagulation. We use local ACD to eliminate extracorporeal surface clotting. Even with massive IAT we have never demonstrated any clinical or laboratory evidence of intravascular coagulopathy. "Dilutional coagulopathy" may be procuced when greater than 5,000 ml are reinfused, and may be controlled with fresh frozen plasma and platelet concentrates. Bilirubin levels were normal after IAT despite gross hemoglobinuria. Fat emboli were not noted after IAT. Air emboli must be a concern in IAT; HOWEVER, PROPER OPERATION AND EQUIPMENT MODIFICATION MAY ELIMINATE EMBOLI. Renal Failure was not noted after IAT. Alveolar-arterial Oxygen Difference and Blood Gases were normal after IAT. We feel IAT is not necessary if a blood loss less than 1,000 ml is expected. Also, if greater than 3,500 ml is expected additional backup (i.e. homologous transfusions, platelets, fresh frozen plasma) may be required. As banked donor blood reserves become more limited, IAT may become a routine part of general surgical procedures.
1)随时可用;2)无菌;3)相容;4)常温;5)价格低廉,且可快速输注以补充血容量。我们对市售设备进行了大量改进,以提供安全、有效的术中自体输血(IAT)。以下概述了IAT在我们85例患者中的效果。红细胞量在IAT后因不可挽回的失血和溶血而减少,必要时可通过同种输血进行控制。IAT后红细胞存活率正常。溶血。IAT后血浆游离血红蛋白持续升高,但在24小时内清除。对于自体输血量少于3500毫升的患者,血小板正常;预计回输血量超过3500毫升的情况下,不应使用微孔过滤器;若回输血量超过3500毫升,每回输3000毫升血液建议输注10单位血小板;IAT确实会影响血小板功能;然而,患者体内循环的血小板功能正常。凝血。我们使用局部ACD来消除体外表面凝血。即使进行大量IAT,我们从未发现任何血管内凝血障碍的临床或实验室证据。当回输量超过5000毫升时,可能会发生“稀释性凝血障碍”,可通过新鲜冰冻血浆和血小板浓缩物进行控制。尽管出现明显血红蛋白尿,但IAT后胆红素水平正常。IAT后未发现脂肪栓塞。空气栓塞在IAT中必须引起关注;然而,正确操作和设备改进可消除栓塞。IAT后未发现肾衰竭。IAT后肺泡-动脉氧分压差和血气正常。我们认为,如果预计失血量少于1000毫升,则无需进行IAT。此外,如果预计失血量超过3500毫升,可能需要额外的备用措施(即同种输血、血小板、新鲜冰冻血浆)。随着库存供血储备变得更加有限,IAT可能会成为普通外科手术的常规组成部分。